1-tert-Butyl 6-methyl 1H-indazole-1,6-dicarboxylate, 95.0%, 250mg

2-Bromo-4-nitropyridine 1-oxide, 95.0%, 1g

4-BROMO-2-IODO-5-METHYLANILINE, 95.0%, 250mg

(R)-2-Amino-6-((tert-butoxycarbonyl)amino)hexanoic acid, 95.0%, 1g

(R)-tert-Butyl (1-(4-bromophenyl)-2-hydroxyethyl)carbamate, 97.0%, 5g

3-methyl-1-(2-methylbenzoyl)piperazine, 95.0%, 5g

5,7-Dichloro-2-methylthiazolo[5,4-d]pyrimidine, 95.0%, 1g

Methyl 2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 5g

Recipiente de reacción con brida plana, cilíndrico, graduado, con camisa de templado y vacío y válvula de drenaje, DN 100, 3000 ml, 250 mm, 1 pieza

Ethyl 5-chloromethyl-[1,2,4]-oxadiadole-3-carboxylate, 95.0%, 1g

3-Methylbenzylamine, 97.0%, 25g

Methyl 1-Boc-5-hydroxypiperidine-3-carboxylate, 95.0%, 250mg

9-Oxa-6-azaspiro[4.5]Decan-7-one, 500mg